New Delhi: Amid growing coronavirus cases across the globe, US researchers gave first shot to the first person in a test of an experimental COVID-19 vaccine yesterday. The said ‘vaccine’, code-named mRNA-1273, was developed by the National Institutes of Health (NIH) and Massachusetts-based biotechnology company Moderna Inc. Also Read - BCCI Not Planning to Cut Virat Kohli and Co. Salaries Amid Coronavirus Pandemic

If reports are to be believed, scientists at the Kaiser Permanente Washington Research Institute in Seattle begin an ‘anxiously awaited first-stage study of a potential COVID-19 vaccine developed in record time’. Jennifer Haller, a 43-year-old woman of Seattle, an operations manager at a tech company, received the injection inside an exam room. Also Read - Hardik Pandya Shares New Fitness Video During Quarantine Period Amid Coronavirus Lockdown | WATCH VIDEO

Haller, the mother of two teenagers, termed it an ‘amazing opportunity’ for her to ‘do something’. Also Read - China Reveals Over 1,300 Asymptomatic Cases of Coronavirus

 Meanwhile, President Donald Trump, at a press conference, praised how quickly the research had progressed.

“Yesterday I spoke with the great American Grocers and Supply Chain Executives. We are confident that supply will continue to meet demand nationwide. These beacons of our community will remain open for you, no matter what. We are working hard to remove any barriers to that effort!”, tweeted the US President.

“I ask all Americans to band together and support your neighbors by not hoarding unnecessary amounts of food and essentials. Together we will stay strong and overcome this challenge,” Trump wrote in another tweet.

Notably, 1,50,000 people have been infected worldwide by the virus which originated in China last December and has claimed the lives of over 6,500 people.